Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting immunostaining in relation to complex human pathologies.TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding. Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
We could not find product '(ID:510202)'. Here are some alternate products to this target that might be of interest to you.
CDC25C, a CDC25 dual specificity protein phosphatase, has been shown to affect the regulation of cell cycle control, and specifically the G2/M progression, through interaction with cdc/cyclin kinases and proliferating cell nuclear antigen (PCNA). Unlike CDC25A and CDC25B, CDC25C does not seem to have oncogenic properties. CDC25C null mutant mice are viable, fertile, and do not display obvious abnomalities. CDC25C expression is regulated by chk1, 14-3-3 protein, p53 and BRCA1, among other proteins. CDC25C is located on chromosome 5p31 near a region that is deleted in some hematologic disorders.
|Gene Name:||cell division cycle 25C|
|Family/Subfamily:||Protein Phosphatase , CDC25|
|Synonyms:||CDC25C, CDC25, CDC25C phosphatase, CDC25Hu3, Cell division cycle 25C, Phosphotyrosine phosphatase, PPP1R60, M-phase inducer phosphatase 3, Mitosis inducer CDC25|
|Target Sequences:||NM_001790 NP_001781.2 P30307|
If you do not find the reagent or information you require, please contact firstname.lastname@example.org to inquire about additional products in development.